Sleep Apnea Devices Market Size By Product (Therapeutics {Airway Clearance System, Adaptive Servo-ventilation {ASV}, Positive Airway Pressure {PAP} Device, Oral Appliances, Oxygen Devices}, Diagnostics {Actigraphy Systems, Polysomnography {PSG} Device, Respiratory Polygraph, Sleep Screening Devices}), By End-use (Home Care Settings & Individuals, Sleep Laboratories & Hospitals), COVID19 Impact Analysis, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027

Published Date: May 2021  |  Report ID: GMI489  |  Authors: Sumant Ugalmugle, Rupali Swain

Report Format: PDF   |   Pages: 200   |   Base Year: 2020




Summary Table of Contents Industry Coverage Methodology

Industry Trends

Sleep Apnea Devices Market size exceeded USD 6 billion in 2020 and is estimated to grow at a CAGR of over 9% between 2021 and 2027. Rising awareness regarding sleep apnea, other sleep disorders and its treatment will impel the market demand.
 

Sleep Apnea Devices Market

Get more details on this report - Request Free Sample PDF
 

COVID-19 pandemic has fueled the demand of sleep apnea devices in home care settings. Advancements in the technology has led to advent of these devices that incorporates telemedicine and remote assessment with the help smartphone. Moreover, in patients diagnosed with COVID-19 infection, Obstructive Sleep Apnea was related with high risk of hospitalization and approximately doubled the risk of respiratory failure.
 

Technological advancements in sleep apnea devices will boost the market growth

In 2020, therapeutics segment revenue in the sleep apnea devices market crossed USD 3.7 billion. The higher size of the segment is attributed to wide range of therapeutic options and constant technological advancements in the equipment. Technological developments are reducing the drawbacks related to the conventional systems, making them more convenient, quieter, and easy to use without causing side effects. The emergence of alternative therapies to conventional continuous positive airway pressure (CPAP) treatment such as minimally invasive neurostimulators and oral appliances has provided broad range of options to the patients.
 

The use of oral appliances in treatment of sleep apnea is growing with its rising popularity and awareness amongst the population. Oral appliances offer over 100 different oral equipment that are approved by the U.S. FDA for treating obstructive sleep apnea and snoring. Integration of computer-assisted development and manufacturing, advancements in plastics, and higher adoption of digital scanning technology will offer more innovations that will enhance comfort as well as compliance.
 

Growing adoption of home care sleep apnea devices will fuel the market demand

Sleep Apnea Devices Market, By End-use

Get more details on this report - Request Free Sample PDF
 

Home care settings & individuals segment value was more than USD 3.3 billion in 2020. The high segment demand is credited to increasing adoption of homecare sleep apnea devices, easy accessibility, and rising awareness regarding treatment availability in home care settings. As per a published research, in 2018, around one-third of obstructive sleep apnea testing was carried out at the patients’ homes and this number has significantly increased from around 15% in 2013.
 

Furthermore, market players are emphasizing on commercialization sleep apnea devices for home care settings. For instance, in June 2019, Itamar Medical received FDA clearance for its WatchPAT One, a completely disposable home sleep apnea test. Similarly, ResMed developed myAir App, a smartphone program for CPAP users that helps in management of sleep apnea. Additionally, favorable reimbursement scenario for home care sleep apnea devices will further channelize the market growth.
 

Rise in incidence of obstructive sleep apnea in North America

Sleep Apnea Devices Market, By Region

Get more details on this report - Request Free Sample PDF
 

U.S. dominated the North America sleep apnea devices market and held largest revenue share of more than 91% in 2020, owing to the shorter sleep duration, high healthcare expenditure and increasing prevalence of obstructive sleep apnea in the country. Obstructive sleep apnea is closely associated with obesity and increasing age. The geriatric population in the U.S. along with high number of obese adults is one of the factors responsible for the rising prevalence of sleep disorders in the country. Around 35% of all adults in the U.S. have reported sleeping less than seven hours on average. Furthermore, the inadequate sleep has an economic burden of over USD 411 billion every year in the U.S.
 

Germany market size was over USD 396 million in 2020, due to high prevalence of chronic conditions such as chronic obstructive pulmonary disease (COPD), asthma & sleep apnea, availability of sleep laboratories & clinics and growing demand for advanced sleep apnea devices in the region. According to the National Institute of Health Research, in Germany, the prevalence of chronic obstructive pulmonary disease (COPD) was approximately 2.7 million in 2019. Chronic ailments such as asthma, chronic obstructive pulmonary disease and other respiratory disorders increase the risk of sleep apnea. The availability of hospitals for treating of sleep apnea and product accessibility in the country will augment the market expansion.
 

Business growth strategies implemented by major industry players

Some of the major players operating in the sleep apnea devices market include BMC Medical, CareFusion Corporation, Cadwell Laboratories, Braebon Medical, Compumedics, Curative Medical, Fisher & Paykel Healthcare, GE Healthcare, ImThera Medical, Invacare Corporation, Natus Medical, Itamar Medical, Philips Healthcare, ResMed, Nihon Kohden, Somnetics International, SOMNOmedics, Weinmann Medical Devices and Teleflex, among others.
 

Several strategic initiatives such as novel product launches, mergers, acquisitions, strategic collaborations, and geographic expansion to gain competitive advantages are being undertaken. These companies also emphasize on research and development activities that allows in garnering maximum revenue.
 

Recent industry developments:

  • In April 2020, Cadwell Laboratories launched ApneaTrak home sleep apnea testing device. This device features three models to meet the clinical requirements to aid in diagnosis of sleep apnea and to validate the efficacy of treatments. This launch helped the company to reinstate its position in home care sleep apnea devices segment.
     

The sleep apnea devices market research report includes an in-depth coverage of the industry with estimates & forecast in terms of revenue in USD from 2016 to 2027, for the following segments:

Market, By Product

  • Therapeutics
    • Airway Clearance Systems
    • Adaptive Servo-ventilation (ASV)
    • Positive Airway Pressure (PAP) Device
    • Oral Appliances
    • Oxygen Devices
    • Others
  • Diagnostics
    • Actigraphy Systems
    • Polysomnography (PSG) Device
    • Respiratory Polygraph
    • Sleep Screening Devices

Market, By End-use

  • Home Care Settings & Individuals
  • Sleep Laboratories & Hospitals

The above information is provided for the following regions and countries:

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Italy
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
  • Latin America
    • Brazil
    • Mexico
    • Argentina
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

 

Frequently Asked Questions (FAQ) :

The market size of sleep apnea devices exceeded USD 6 billion in 2020 and is estimated to grow at a CAGR of over 9% between 2021 and 2027.
In 2020, therapeutics segment revenue in market crossed USD 3.7 billion. The higher size of the segment is attributed to wide range of therapeutic options and constant technological advancements in the equipment.
Home care settings & individuals segment value was more than USD 3.3 billion in 2020. The high segment demand is credited to increasing adoption of homecare sleep apnea devices, easy accessibility, and rising awareness regarding treatment availability in home care settings.
U.S. dominated the North America market and held largest revenue share of more than 91% in 2020, owing to the shorter sleep duration, high healthcare expenditure and increasing prevalence of obstructive sleep apnea in the country.
Some of the major players operating in the market include BMC Medical, CareFusion Corporation, Cadwell Laboratories, Braebon Medical, Compumedics, Curative Medical, Fisher & Paykel Healthcare, GE Healthcare, ImThera Medical, Invacare Corporation, Natus Medical, Itamar Medical, Philips Healthcare, ResMed, Nihon Kohden, Somnetics International, SOMNOmedics, Weinmann Medical Devices and Teleflex, among others.

Premium Report Details

  • Published Date: May 2021
  • Pages: 200
  • Tables: 231
  • Charts / Figures: 14
  • Companies covered: 19
  • Countries covered: 18

Get a report that explains COVID-19 impact on this market

Buy Now

Need a Discount? Get in touch with us for special pricing

Request Discount

 Connect with our sales team

Chat with us
We use cookies to enhance user experience. (Privacy Policy) X